A review of the relationship between parenteral nutrition and metabolic bone disease.
暂无分享,去创建一个
[1] B. Kinosian,et al. Intestinal failure-associated metabolic bone diseases and response to teriparatide. , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[2] M. Baun,et al. Metabolic bone disease in patients receiving home parenteral nutrition: a Canadian study and review. , 2006, JPEN. Journal of parenteral and enteral nutrition.
[3] R. Écochard,et al. Fluoride exposure and bone status in patients with chronic intestinal failure who are receiving home parenteral nutrition. , 2006, The American journal of clinical nutrition.
[4] M. Puder,et al. Recent developments in aluminium contamination of products used in parenteral nutrition , 2006, Current opinion in clinical nutrition and metabolic care.
[5] M. Staun,et al. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. , 2004, JPEN. Journal of parenteral and enteral nutrition.
[6] D. Young. FDA aluminum rule poses challenges for industry, pharmacists. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[7] T. Yoshikawa,et al. Long-term total parenteral nutrition and osteoporosis: Report of a case , 2004, Surgery Today.
[8] C. Baudoin,et al. Osteoporosis in Patients on Long‐Term Home Parenteral Nutrition: A Longitudinal Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] J. Siepler,et al. Intravenous pamidronate improves bone mineral density in home parenteral nutrition patients , 2003 .
[10] M. Staun,et al. Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition. , 2002, The American journal of clinical nutrition.
[11] A. Van Gossum,et al. Prevalence of bone disease in patients on home parenteral nutrition. , 2002, Clinical nutrition.
[12] H. Bitter,et al. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study. , 2001, Scandinavian journal of gastroenterology.
[13] L. Schurgers,et al. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? , 2001, Gut.
[14] C. Bernstein,et al. The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study , 2000, Annals of Internal Medicine.
[15] S. Manolagas. Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] M. Shiraki,et al. Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] B. Vainer,et al. Established and emerging biological activity markers of inflammatory bowel disease. , 2000, The American journal of gastroenterology.
[18] P. Miller,et al. Antifracture efficacy of antiresorptive agents are related to changes in bone density. , 2000, The Journal of clinical endocrinology and metabolism.
[19] N. Watts,et al. Clinical utility of biochemical markers of bone remodeling. , 1999, Clinical chemistry.
[20] R. Jilka,et al. Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. , 1998, Bone.
[21] Robinson,et al. Increased bone resorption in patients with Crohn’s disease , 1998, Alimentary pharmacology & therapeutics.
[22] J. Bonjour,et al. Fluoride: mode of action. , 1998, Bone.
[23] E. Lipkin. Metabolic bone disease in gut diseases. , 1998, Gastroenterology clinics of North America.
[24] Z. Tulassay,et al. Altered Bone Metabolism in Inflammatory Bowel Disease , 1998, American Journal of Gastroenterology.
[25] L. Sokoll,et al. Bioavailability of phylloquinone from an intravenous lipid emulsion. , 1998, The American journal of clinical nutrition.
[26] J. Jahnsen,et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. , 1997, Gut.
[27] D. Eyre,et al. Molecular basis and clinical application of biological markers of bone turnover. , 1996, Endocrine reviews.
[28] L. Sokoll,et al. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. , 1996, The American journal of clinical nutrition.
[29] J. Douketis,et al. The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density , 1996, Thrombosis and Haemostasis.
[30] K. Jeejeebhoy,et al. Increase in Lumbar Spine Bone Mineral Content in Patients on Long-Term Parenteral Nutrition Without Vitamin D Supplementation , 1995 .
[31] T. Yoneda,et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] M. Dougados,et al. Metabolic bone assessment in patients with inflammatory bowel disease. , 1995, Gastroenterology.
[33] M. Tohkin,et al. Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. , 1994, Biochemical and biophysical research communications.
[34] J. Conly,et al. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. , 1994, The American journal of gastroenterology.
[35] S. Epstein,et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. , 1994, Transplantation.
[36] J. Eisman,et al. Bone loss after heart transplantation: a prospective study. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[37] J. Coburn,et al. Total parenteral nutrition and its effects on bone metabolism. , 1994, Critical reviews in clinical laboratory sciences.
[38] P. Delmas,et al. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] J. Mason,et al. The vitamin K content of intravenous lipid emulsions. , 1993, JPEN. Journal of parenteral and enteral nutrition.
[40] K. Khaw,et al. Sex hormones and bone mineral density in elderly men. , 1993, Bone and mineral.
[41] R. Glynn,et al. Vitamin K and maintenance of skeletal integrity in adults. , 1993, The American journal of medicine.
[42] P. Delmas,et al. Circulating levels of vitamin K1 and K2 are decreased in elderly women with hip fracture , 1992 .
[43] P. Delmas,et al. Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. , 1992, Endocrinology.
[44] J. Schölmerich,et al. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. , 1992, Gastroenterology.
[45] M. Shike,et al. Aluminum and TPN-related bone disease. , 1992, The American journal of clinical nutrition.
[46] O. Goulet,et al. Calcium Metabolism in Children During Long‐Term Total Parenteral Nutrition: The Influence of Calcium, Phosphorus, and Vitamin D Intakes , 1991, Journal of pediatric gastroenterology and nutrition.
[47] G. Meade,et al. The solubility of calcium and phosphorus in neonatal total parenteral nutrition solutions. , 1991, JPEN. Journal of parenteral and enteral nutrition.
[48] R. Vieth. The mechanisms of vitamin D toxicity. , 1990, Bone and mineral.
[49] C. Fiore,et al. Reduced Axial Bone Mineral Content in Patients Taking an Oral Anticoagulant , 1990, Southern medical journal.
[50] R. Steinberg,et al. Progressive bone loss during long-term home total parenteral nutrition. , 1990, JPEN. Journal of parenteral and enteral nutrition.
[51] M. Mcmahon,et al. Long-term parenteral nutrition and metabolic bone disease. , 1990, Endocrinology and metabolism clinics of North America.
[52] P. Schlesinger,et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. , 1990, The Journal of clinical investigation.
[53] S. McDiarmid,et al. Is fluoride deficiency related to the bone disease of parenteral nutrition (PN) , 1990 .
[54] E. Bonucci,et al. Bone loss in response to long-term glucocorticoid therapy. , 1990, Bone and mineral.
[55] A. Crawford,et al. Fractures and Rickets in Very Low Birth Weight Infants: Conservative Management and Outcome , 1989, Journal of pediatric orthopedics.
[56] S. Ott,et al. D-lactate and metabolic bone disease in patients receiving long-term parenteral nutrition. , 1989, JPEN. Journal of parenteral and enteral nutrition.
[57] W. Koo,et al. Minimal Vitamin D and High Calcium and Phosphorus Needs of Preterm Infants Receiving Parenteral Nutrition , 1989, Journal of pediatric gastroenterology and nutrition.
[58] E. Horak,et al. Simultaneous infusion of calcium and phosphorus in parenteral nutrition for premature infants: use of physiologic calcium/phosphorus ratio. , 1989, The Journal of pediatrics.
[59] S. Ott,et al. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. , 1988, The American journal of clinical nutrition.
[60] G. Bacci,et al. The effects of methotrexate (MTX) on bone. A densitometric study conducted on 59 patients with MTX administered at different doses. , 1988, Italian journal of orthopaedics and traumatology.
[61] W. Koo,et al. Sequential bone mineral content in small preterm infants with and without fractures and rickets , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[62] S. Ott,et al. Mineral loss in the parenteral nutrition patient. , 1988, The American journal of clinical nutrition.
[63] J. Lian,et al. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. , 1987, American journal of human genetics.
[64] H. Wahner. Single- and dual-photon absorptiometry in osteoporosis and osteomalacia. , 1987, Seminars in nuclear medicine.
[65] R F Kilcoyne,et al. Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[66] I. Reid,et al. Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. , 1987, Hormone research.
[67] M. Holick,et al. Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. , 1986, The American journal of clinical nutrition.
[68] W. Koo,et al. Response to aluminum in parenteral nutrition during infancy. , 1986, The Journal of pediatrics.
[69] M. Holick,et al. Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. , 1986, The American journal of clinical nutrition.
[70] S. Epstein,et al. Bone and mineral status of patients beginning total parenteral nutrition. , 1986, JPEN. Journal of parenteral and enteral nutrition.
[71] M. Mackay,et al. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing TrophAmine. , 1986, American journal of hospital pharmacy.
[72] A. Sedman,et al. Evidence of aluminum loading in infants receiving intravenous therapy. , 1985, The New England journal of medicine.
[73] I. Rosenberg,et al. Calciuretic effect of cyclic versus continuous total parenteral nutrition. , 1985, The American journal of clinical nutrition.
[74] M. de Vernejoul,et al. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition. , 1985, The Journal of clinical endocrinology and metabolism.
[75] T. Vanderveen,et al. Compatibility considerations in parenteral nutrient solutions. , 1984, American journal of hospital pharmacy.
[76] D. Henry,et al. Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. , 1984, Kidney international.
[77] W. Koo,et al. Bone mineralization in infants. , 1984, Progress in food & nutrition science.
[78] P. Reitsma,et al. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[79] I. Rosenberg,et al. Amino acid-induced hypercalciuria in patients on total parenteral nutrition. , 1983, The American journal of clinical nutrition.
[80] J. Kerner,et al. Calcium and phosphorus in neonatal parenteral nutrition solutions. , 1983, JPEN. Journal of parenteral and enteral nutrition.
[81] S. Ott,et al. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. , 1983, Annals of internal medicine.
[82] P. Knight,et al. CaxP and Ca/P in the parenteral feeding of preterm infants. , 1983, JPEN. Journal of parenteral and enteral nutrition.
[83] D. White,et al. Calcium and Phosphorus Metabolism During Total Parenteral Nutrition , 1983, Annals of surgery.
[84] I. Rosenberg,et al. Vitamin D deficiency and bone disease in patients with Crohn's disease. , 1982, Gastroenterology.
[85] D. Sherrard,et al. Aluminum loading during total parenteral nutrition. , 1982, The American journal of clinical nutrition.
[86] D. Batton,et al. Rickets associated with cholestasis and parenteral nutrition in premature infants. , 1982, Radiology.
[87] R. A. Cannon,et al. Infantile vitamin D-resistant rickets associated with total parenteral nutrition. , 1982, American journal of diseases of children.
[88] B. Kirschner,et al. Lactose malabsorption in children and adolescents with inflammatory bowel disease. , 1981, Gastroenterology.
[89] J. Harrison,et al. A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease. , 1981, Annals of internal medicine.
[90] R. Lindsay,et al. PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN , 1980, The Lancet.
[91] A. Norman,et al. BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITION , 1980, The Lancet.
[92] R. A. Cannon,et al. Home parenteral nutrition in infants. , 1980, The Journal of pediatrics.
[93] J. Harrison,et al. Metabolic bone disease in patients receiving long-term total parenteral nutrition. , 1980, Annals of internal medicine.
[94] Y. Kim,et al. Effect of level of protein intake on calcium metabolism and on parathyroid and renal function in the adult human male. , 1979, The Journal of nutrition.
[95] S. Krane,et al. Metabolic bone disease , 1977 .
[96] J. Harrison,et al. Calcium kinetic studies in patients with malabsorption syndrome. , 1969, Gastroenterology.
[97] A. Relman,et al. PRODUCTION, EXCRETION, AND NET BALANCE OF FIXED ACID IN PATIENTS WITH RENAL ACIDOSIS. , 1965, The Journal of clinical investigation.
[98] P. Goldhaber. Heparin Enhancement of Factors Stimulating Bone Resorption in Tissue Culture , 1965, Science.